SKBI...BTW, organic growth alone has been running at 40%+. Even if organic growth slows a notch, $3 EPS+ is doable considering the acquisitions and the vaccine facility. I just don't understand why analysts are coming in w/ such low EPS numbers for 2011?? What am I'm missing? We'll see what happens...